» Articles » PMID: 23369277

Haemophilus Influenzae and the Lung (Haemophilus and the Lung)

Overview
Journal Clin Transl Med
Publisher Wiley
Specialty General Medicine
Date 2013 Feb 2
PMID 23369277
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Haemophilus influenzae is present as a commensal organism in the nasopharynx of most healthy adults from where it can spread to cause both systemic and respiratory tract infection. This bacterium is divided into typeable forms (such as type b) or nontypeable forms based on the presence or absence of a tough polysaccharide capsule. Respiratory disease is predominantly caused by the nontypeable forms (NTHi). Haemophilus influenzae has evolved a number of strategies to evade the host defense including the ability to invade into local tissue. Pathogenic properties of this bacterium as well as defects in host defense may result in the spread of this bacterium from the upper airway to the bronchi of the lung. This can result in airway inflammation and colonization particularly in chronic obstructive pulmonary disease. Treatment of respiratory tract infection with Haemophilus influenzae is often only partially successful with ongoing infection and inflammation. Improvement in patient outcome will be dependent on a better understanding of the pathogenesis and host immune response to this bacterium.

Citing Articles

Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency.

Lee J, Mohammad N, Han K, Flagg-Dowie T, Magallon M, Brantly M Front Immunol. 2025; 16:1543729.

PMID: 40013145 PMC: 11861504. DOI: 10.3389/fimmu.2025.1543729.


Comparing sputum, nasopharyngeal swabs, and combined samples for respiratory bacterial detection using multiplex PCR.

Kim K, Yun S, Nam M, Lee C, Cho Y Microbiol Spectr. 2025; 13(3):e0228524.

PMID: 39882879 PMC: 11878093. DOI: 10.1128/spectrum.02285-24.


Respiratory tract infections: an update on the complexity of bacterial diversity, therapeutic interventions and breakthroughs.

Panickar A, Manoharan A, Anbarasu A, Ramaiah S Arch Microbiol. 2024; 206(9):382.

PMID: 39153075 DOI: 10.1007/s00203-024-04107-z.


Tolerance to Haemophilus influenzae infection in human epithelial cells: Insights from a primary cell-based model.

Kappler U, Henningham A, Nasreen M, Yamamoto A, Buultjens A, Stinear T PLoS Pathog. 2024; 20(7):e1012282.

PMID: 38990812 PMC: 11239077. DOI: 10.1371/journal.ppat.1012282.


Chronic Bronchitis in Children and Adults: Definitions, Pathophysiology, Prevalence, Risk Factors, and Consequences.

Zhang J, Wurzel D, Perret J, Lodge C, Walters E, Dharmage S J Clin Med. 2024; 13(8).

PMID: 38673686 PMC: 11051495. DOI: 10.3390/jcm13082413.


References
1.
King P, Ngui J, Gunawardena D, Holmes P, Farmer M, Holdsworth S . Systemic humoral immunity to non-typeable Haemophilus influenzae. Clin Exp Immunol. 2008; 153(3):376-84. PMC: 2527355. DOI: 10.1111/j.1365-2249.2008.03697.x. View

2.
Krasan G, Cutter D, Block S, St Geme 3rd J . Adhesin expression in matched nasopharyngeal and middle ear isolates of nontypeable Haemophilus influenzae from children with acute otitis media. Infect Immun. 1998; 67(1):449-54. PMC: 96336. DOI: 10.1128/IAI.67.1.449-454.1999. View

3.
Zwahlen A, Kroll J, Rubin L, Moxon E . The molecular basis of pathogenicity in Haemophilus influenzae: comparative virulence of genetically-related capsular transformants and correlation with changes at the capsulation locus cap. Microb Pathog. 1989; 7(3):225-35. DOI: 10.1016/0882-4010(89)90058-2. View

4.
St Geme 3rd J . The pathogenesis of nontypable Haemophilus influenzae otitis media. Vaccine. 2001; 19 Suppl 1:S41-50. DOI: 10.1016/s0264-410x(00)00277-2. View

5.
Gaschler G, Skrtic M, Zavitz C, Lindahl M, Onnervik P, Murphy T . Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med. 2009; 179(8):666-75. DOI: 10.1164/rccm.200808-1306OC. View